![[aggregator] downloaded image for imported item #135616](https://newsview.top/wp-content/uploads/2026/10/woman-at-cardiologist-1024x576.jpg "Weight-loss drugs may fight 7 serious health problems before the pounds even come off")
This post was originally published on this site.
GLP-1 medicationsmay provide health benefits that extend beyond weight loss, according to a growing body of research.
From reducing cardiovascular risks to potentially easing joint pain and inflammation, studies suggest these drugs may affect multiple systems throughout the body.
Here are seven potential benefits beyondshedding pounds.
POPULAR WEIGHT-LOSS STRATEGY SHOWS SURPRISING POTENTIAL FOR CHRONIC PAIN RELIEF
No.1: Protecting heart health
Research suggests semaglutide — the active ingredient in Ozempic and Wegovy — may providecardiovascular benefitsbeyond those associated with weight loss.
A major study published in The Lancet found that semaglutide reduced the risk of heart attacks, strokes and cardiovascular death among people with existing cardiovascular disease and overweight or obesity.The benefits were observed across different body weights and were not fully explained by weight loss.
Semaglutide has been shown to reduce cardiovascular risks, with benefits that appear to extend beyond weight loss.(iStock)
No.2: Reducing joint pain and improving mobility
GLP-1 medications have been linked to reduced joint pain, although researchers are still investigating how much of the benefit comes from weight loss versus other effects.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
The STEP 9 clinical trial, published in the New England Journal of Medicine, found that semaglutide significantly reducedknee osteoarthritis painand improved physical function among adults with obesity.
Research suggests GLP-1 medications may help reduce knee osteoarthritis pain, although their ability to repair damaged cartilage has not been established.(iStock)
No.3: Promoting kidney health
GLP-1 medications may help protect kidney function through several mechanisms, including improvements in blood sugar,blood pressureand inflammation.
GLP-1 BOOM COULD RESHAPE RESTAURANT BARS AS DINERS CUT BACK ON ALCOHOL
In the landmark FLOW trial, published in the New England Journal of Medicine, semaglutide reduced the risk of major kidney-related complications and cardiovascular death by 24% among patients with type 2 diabetes and chronic kidney disease.
No.4: Reducing liver inflammation and scarring
MASH, or metabolic dysfunction-associated steatohepatitis, is a more severe form of fatty liver disease involving inflammation and liver cell damage.
Research suggests GLP-1 medications may help improve liver health, although the extent to which these benefits occur independently of weight loss remains under investigation.
Clinical trials have found that semaglutide can slow the progression of kidney disease in certain patients.(iStock)
A clinical trial published in the New England Journal of Medicine found that semaglutide improved liver tissue findings among patients with MASH, including reductions in inflammation and liver scarring.
Researchers found that 62.9% of semaglutide recipients experienced resolution of MASH without worsening liver fibrosis, compared with 34.3% receiving placebo.
No.5: Reducing respiratory flare-ups
Real-world research presented at the European Respiratory Society Congress has linked GLP-1 medications to fewerasthma attacksand COPD flare-ups.
Researchers believe the drugs’ potential anti-inflammatory effects may play a role, although additional studies are needed to determine whether the medications directly improve respiratory health.
No.6: Supporting mental health and curbing addiction
The brain contains GLP-1 receptors in regions involved in regulating appetite, emotions, motivation and responses to rewards.
Emerging research suggests semaglutide may have potential benefits for mental health andaddiction.
onelink.me/xLDS?pid=AppArticleLink&af_web_dp=https%3A%2F%2Fwww.
An observational study published on the preprint server medRxiv linked semaglutide use to lower rates of substance-related andmood disorders.However, the findings have not been peer-reviewed and do not establish that the medication caused the reductions.
Preliminary research has linked semaglutide use to lower rates of certain substance-related and mood disorders, although further studies are needed.(iStock)
No.7: Soothing severe skin conditions
GLP-1-based medications are also being investigated for their potential benefits in inflammatoryskin conditions, including psoriasis.
A clinical trial published in JAMA Dermatology found that adding tirzepatide to an existing psoriasis treatment improved skin clearance among adults with moderate to severe psoriasis and overweight or obesity.
The effects of GLP-1 medications can vary by drug and individual, and patients should consult a healthcare provider about potential risks and benefits.
![[aggregator] downloaded image for imported item #118279](https://newsview.top/wp-content/uploads/2026/08/INT_3Dclip03_NOSOUND-1024x576.jpg "Cancer vaccine prevents deadly melanoma from returning or spreading in landmark trial")
![[aggregator] downloaded image for imported item #118572](https://newsview.top/wp-content/uploads/2026/08/hilaria-goal-post-arms-1024x576.jpg "Hilaria Baldwin shares 5 simple stretches to do at work to prevent pain and stiffness")
![[aggregator] downloaded image for imported item #118822](https://newsview.top/wp-content/uploads/2026/08/serger-hardy-beach-1024x576.jpg "Navy veterans reunite after 30 years for 'grueling' cross-country bike challenge honoring 9/11")
![[aggregator] downloaded image for imported item #118814](https://newsview.top/wp-content/uploads/2026/08/child_ecg-1024x576.jpg "Healthy athlete had no symptoms before mandatory heart screening revealed hidden defect")